arrow
C

Cédric van Marcke

king albert ii cancer institute and cliniques universitaires saint luc
H指数:17
被引数:868

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors

Beamion PANTUMOR-1: Zongertinib二线临床试验的试验依据与设计,用于HER2过表达/扩增或HER2突变的实体瘤

2026-03-040
PRE
Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer

评估短疗程度伐利尤单抗联合高密度EC方案在局部晚期luminal B/HER2(-)或三阴性乳腺癌新辅助治疗中的效果

2025-11-280
OAAI
Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial-mesenchymal transition and tumor-infiltrating lymphocytes

早期乳腺癌对新辅助化疗的反应与上皮间质转化和肿瘤浸润淋巴细胞有关

2025-02-060
OAAI
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma

PPARα介导的脂质代谢重编程支持头颈部鳞状细胞癌中抗EGFR疗法的耐药性。

2025-02-010
OA
Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours
2024-05-131
OAAI
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor

循环肿瘤DNA的肿瘤不可知血浆测定可预测用PD-1抑制剂治疗的头颈部复发和/或转移性鳞状细胞癌的结果

2023-12-010
PRE
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

循环肿瘤DNA的肿瘤不可知血浆测定可检测微小残留疾病并预测头颈部局部晚期鳞状细胞癌的预后

2023-12-0115
OA
Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
2023-10-010
OA
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future
2022-12-011
OAAI
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

PRECISION: 用于临床决策和治疗分配的转移性癌症的比利时分子谱分析计划

2022-08-014
OAAI